Search research articles
Contact Us
Filters
Showing results (141-150 of 149) with videos related to
Page
of 15
Sort By:
You have reached the last page of results.
This site can display upto 149 results.
European Journal of Endocrinology
|
February 9, 2007
Effect of 2 years of high-dose growth hormone therapy on cognitive and psychosocial development in short children born small for gestational age
K Lagrou, J Vanderfaeillie, C Froidecoeur, et al.
Hormone Research
|
May 28, 2008
Concerns, expectations and perception regarding stature, physical appearance and psychosocial functioning before and during high-dose growth hormone treatment of short pre-pubertal children born small for gestational age
K Lagrou, C Froidecoeur, M Thomas, et al.
Orphanet Journal of Rare Diseases
|
September 3, 2015
Evaluation of the hypothalamic-pituitary-adrenal axis and its relationship with central respiratory dysfunction in children with Prader-Willi syndrome
Veronique Beauloye, K Dhondt, W Buysse, et al.
Journal of Clinical Pharmacology
|
October 12, 2000
Comparative inhibitory activity of rofecoxib, meloxicam, diclofenac, ibuprofen, and naproxen on COX-2 versus COX-1 in healthy volunteers
A Van Hecken, J I Schwartz, M Depré, et al.
Hormone Research
|
August 18, 2001
Final height in children with idiopathic growth hormone deficiency treated with recombinant human growth hormone: the Belgian experience
M Thomas, G Massa, J P Bourguignon, et al.
The Journal of Clinical Endocrinology and Metabolism
|
May 1, 1996
High-dose growth hormone treatment of short children born small for gestational age
F de Zegher, M Maes, S E Gargosky, et al.
European Journal of Endocrinology
|
November 8, 2012
Novel H6PDH mutations in two girls with premature adrenarche: 'apparent' and 'true' CRD can be differentiated by urinary steroid profiling
G G Lavery, J Idkowiak, M Sherlock, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 1, 1996
Effect of MK-386, a novel inhibitor of type 1 5 alpha-reductase, alone and in combination with finasteride, on serum dihydrotestosterone concentrations in men
J I Schwartz, A Van Hecken, P J De Schepper, et al.
Pharmacogenetics
|
May 8, 2001
In-vitro metabolism of celecoxib, a cyclooxygenase-2 inhibitor, by allelic variant forms of human liver microsomal cytochrome P450 2C9: correlation with CYP2C9 genotype and in-vivo pharmacokinetics
C Tang, M Shou, T H Rushmore, et al.
Page
of 15
Search research articles
Search
Showing results (141-150 of 149) with videos related to
Sort By:
Page
of 15
You have reached the last page of results.
This site can display upto 149 results.
European Journal of Endocrinology
|
February 9, 2007
Effect of 2 years of high-dose growth hormone therapy on cognitive and psychosocial development in short children born small for gestational age
K Lagrou, J Vanderfaeillie, C Froidecoeur, et al.
Hormone Research
|
May 28, 2008
Concerns, expectations and perception regarding stature, physical appearance and psychosocial functioning before and during high-dose growth hormone treatment of short pre-pubertal children born small for gestational age
K Lagrou, C Froidecoeur, M Thomas, et al.
Orphanet Journal of Rare Diseases
|
September 3, 2015
Evaluation of the hypothalamic-pituitary-adrenal axis and its relationship with central respiratory dysfunction in children with Prader-Willi syndrome
Veronique Beauloye, K Dhondt, W Buysse, et al.
Journal of Clinical Pharmacology
|
October 12, 2000
Comparative inhibitory activity of rofecoxib, meloxicam, diclofenac, ibuprofen, and naproxen on COX-2 versus COX-1 in healthy volunteers
A Van Hecken, J I Schwartz, M Depré, et al.
Hormone Research
|
August 18, 2001
Final height in children with idiopathic growth hormone deficiency treated with recombinant human growth hormone: the Belgian experience
M Thomas, G Massa, J P Bourguignon, et al.
The Journal of Clinical Endocrinology and Metabolism
|
May 1, 1996
High-dose growth hormone treatment of short children born small for gestational age
F de Zegher, M Maes, S E Gargosky, et al.
European Journal of Endocrinology
|
November 8, 2012
Novel H6PDH mutations in two girls with premature adrenarche: 'apparent' and 'true' CRD can be differentiated by urinary steroid profiling
G G Lavery, J Idkowiak, M Sherlock, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 1, 1996
Effect of MK-386, a novel inhibitor of type 1 5 alpha-reductase, alone and in combination with finasteride, on serum dihydrotestosterone concentrations in men
J I Schwartz, A Van Hecken, P J De Schepper, et al.
Pharmacogenetics
|
May 8, 2001
In-vitro metabolism of celecoxib, a cyclooxygenase-2 inhibitor, by allelic variant forms of human liver microsomal cytochrome P450 2C9: correlation with CYP2C9 genotype and in-vivo pharmacokinetics
C Tang, M Shou, T H Rushmore, et al.
Page
of 15